Ribosome hibernation: a new molecular framework for targeting nonreplicating persisters of mycobacteria

Microbiology (Reading). 2021 Feb;167(2):001035. doi: 10.1099/mic.0.001035.

Abstract

Treatment of tuberculosis requires a multi-drug regimen administered for at least 6 months. The long-term chemotherapy is attributed in part to a minor subpopulation of nonreplicating Mycobacterium tuberculosis cells that exhibit phenotypic tolerance to antibiotics. The origins of these cells in infected hosts remain unclear. Here we discuss some recent evidence supporting the hypothesis that hibernation of ribosomes in M. tuberculosis, induced by zinc starvation, could be one of the primary mechanisms driving the development of nonreplicating persisters in hosts. We further analyse inconsistencies in previously reported studies to clarify the molecular principles underlying mycobacterial ribosome hibernation.

Keywords: Mycobacterium tuberculosis; cryo-EM structure analysis; drug tolerance; nonreplicating persisters; ribosome hibernation; zinc starvation.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Antitubercular Agents / metabolism
  • Antitubercular Agents / therapeutic use
  • Bacterial Proteins / chemistry
  • Bacterial Proteins / metabolism
  • Drug Resistance, Bacterial
  • Humans
  • Mycobacterium / drug effects
  • Mycobacterium / metabolism
  • Mycobacterium / physiology*
  • Ribosomal Proteins / chemistry
  • Ribosomal Proteins / metabolism
  • Ribosomes / metabolism
  • Tuberculosis / drug therapy
  • Tuberculosis / microbiology*
  • Zinc / deficiency

Substances

  • Antitubercular Agents
  • Bacterial Proteins
  • Ribosomal Proteins
  • Zinc